These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells. Ghaffari M; Dehghan G; Baradaran B; Zarebkohan A; Mansoori B; Soleymani J; Ezzati Nazhad Dolatabadi J; Hamblin MR Colloids Surf B Biointerfaces; 2020 Apr; 188():110762. PubMed ID: 31911391 [TBL] [Abstract][Full Text] [Related]
4. Targeting Breast Cancer Cells with G4 PAMAM Dendrimers and Valproic Acid Derivative Complexes. Muñoz AM; Fragoso-Vázquez MJ; Martel BP; Chávez-Blanco A; Dueñas-González A; R García-Sánchez J; Bello M; Romero-Castro A; Correa-Basurto J Anticancer Agents Med Chem; 2020; 20(15):1857-1872. PubMed ID: 32324521 [TBL] [Abstract][Full Text] [Related]
5. Biocompatible PAMAM-PLGA-PCL Nanocarrier for Efficient Curcumin Delivery to Lung Cancer Cells: In Vitro Studies. Qasim Almajidi Y; Jawad AQ; Abdulameer Albadri A Chem Biodivers; 2024 Oct; 21(10):e202401106. PubMed ID: 39012926 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer. Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021 [TBL] [Abstract][Full Text] [Related]
7. Poly(amidoamine) Dendrimers as Nanocarriers for 5-Fluorouracil: Effectiveness of Complex Formation and Cytotoxicity Studies. Szota M; Reczyńska-Kolman K; Pamuła E; Michel O; Kulbacka J; Jachimska B Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681827 [TBL] [Abstract][Full Text] [Related]
8. Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo. Liu C; Liu X; Rocchi P; Qu F; Iovanna JL; Peng L Bioconjug Chem; 2014 Mar; 25(3):521-32. PubMed ID: 24494983 [TBL] [Abstract][Full Text] [Related]
9. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy. Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609 [TBL] [Abstract][Full Text] [Related]
10. Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release. Thanh VM; Nguyen TH; Tran TV; Ngoc UP; Ho MN; Nguyen TT; Chau YNT; Le VT; Tran NQ; Nguyen CK; Nguyen DH Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():291-298. PubMed ID: 29025661 [TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory and anti-oxidant activity of anionic dendrimer-N-acetyl cysteine conjugates in activated microglial cells. Wang B; Navath RS; Romero R; Kannan S; Kannan R Int J Pharm; 2009 Jul; 377(1-2):159-68. PubMed ID: 19463931 [TBL] [Abstract][Full Text] [Related]
12. α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy. Bhatt H; Kiran Rompicharla SV; Ghosh B; Biswas S Mol Pharm; 2019 Apr; 16(4):1541-1554. PubMed ID: 30817166 [TBL] [Abstract][Full Text] [Related]
13. Folic acid-decorated polyamidoamine dendrimer exhibits high tumor uptake and sustained highly localized retention in solid tumors: Its utility for local siRNA delivery. Xu L; Yeudall WA; Yang H Acta Biomater; 2017 Jul; 57():251-261. PubMed ID: 28438704 [TBL] [Abstract][Full Text] [Related]
14. Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo. Navarro G; Tros de Ilarduya C Nanomedicine; 2009 Sep; 5(3):287-97. PubMed ID: 19523431 [TBL] [Abstract][Full Text] [Related]
15. PAMAM Dendrimer Nanomolecules Utilized as Drug Delivery Systems for Potential Treatment of Glioblastoma: A Systematic Review. Fana M; Gallien J; Srinageshwar B; Dunbar GL; Rossignol J Int J Nanomedicine; 2020; 15():2789-2808. PubMed ID: 32368055 [TBL] [Abstract][Full Text] [Related]
16. Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers. Pisal DS; Yellepeddi VK; Kumar A; Kaushik RS; Hildreth MB; Guan X; Palakurthi S Int J Pharm; 2008 Feb; 350(1-2):113-21. PubMed ID: 17913410 [TBL] [Abstract][Full Text] [Related]
17. The influence of PAMAM dendrimers surface groups on their interaction with porcine pepsin. Ciolkowski M; Rozanek M; Bryszewska M; Klajnert B Biochim Biophys Acta; 2013 Oct; 1834(10):1982-7. PubMed ID: 23851144 [TBL] [Abstract][Full Text] [Related]
19. Unilateral Administration of Surface-Modified G1 and G4 PAMAM Dendrimers in Healthy Mice to Assess Dendrimer Migration in the Brain. Srinageshwar B; Thompson C; Otero P; Story DT; Wedster AE; MacDonald B; Munro N; Koneru S; Crandall R; Swanson D; Sharma A; Dunbar GL; Rossignol J ACS Appl Mater Interfaces; 2024 Aug; 16(32):41907-41915. PubMed ID: 39083440 [TBL] [Abstract][Full Text] [Related]
20. PAMAM dendrimers augment inhibitory effects of curcumin on cancer cell proliferation: possible inhibition of telomerase. Mollazade M; Nejati-Koshki K; Akbarzadeh A; Zarghami N; Nasiri M; Jahanban-Esfahlan R; Alibakhshi A Asian Pac J Cancer Prev; 2013; 14(11):6925-8. PubMed ID: 24377627 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]